These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 14435562)

  • 1. Comparative studies of erythromycin propionate, erythromycin stearate, and triacetyloleandomycin.
    QUINN EL; COLVILLE JM; COX F
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():103-8. PubMed ID: 14435562
    [No Abstract]   [Full Text] [Related]  

  • 2. Hepatic dysfunction associated with triacetyloleandomycin and propionyl erythromycin ester lauryl sulfate.
    ROBINSON MM
    Am J Med Sci; 1962 Apr; 243():502-10. PubMed ID: 14492926
    [No Abstract]   [Full Text] [Related]  

  • 3. Erythromycin, oleandomycin and triacetyloleandomycin.
    Ross S
    Pediatr Clin North Am; 1968 Feb; 15(1):119-29. PubMed ID: 4867776
    [No Abstract]   [Full Text] [Related]  

  • 4. Cholestatic hepatitis caused by esters of erythromycin and oleandomycin.
    GILBERT FI
    JAMA; 1962 Dec; 182():1048-50. PubMed ID: 13947810
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of food on the absorption of erythromycin propionate, erythromycin stearate and triacetyloleandomycin.
    HIRSCH HA; FINLAND M
    Am J Med Sci; 1959 Jun; 237(6):693-709. PubMed ID: 13661157
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experiences with the antibiotic triacetyloleandomycin and the combination preparation tetracycline-oleandomycin in childhood].
    DIETEL V; MEISSNER F
    Dtsch Gesundheitsw; 1961 Dec; 16():2470-4. PubMed ID: 13886293
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new anti-staphylococcal agent of value: triacetyloleandomycin. Results of the treatment of various staphylococcias by triacetyloleandomycin in hospital milieu].
    KOSKAS R; ZIRAH P
    Tunis Med; 1961; 39():615-26. PubMed ID: 14458647
    [No Abstract]   [Full Text] [Related]  

  • 8. Effectiveness of triacetyloleandomycin: in vitro and in vivo studies.
    WERTHAMER S; PECORA CL
    Antibiotic Med Clin Ther (New York); 1960 Sep; 7():560-5. PubMed ID: 13844064
    [No Abstract]   [Full Text] [Related]  

  • 9. [Triacetyloleandomycin (P.A. 777)].
    WAREMBOURG H; DESMET G; LEKIEFFRE J
    Lille Med; 1961 Mar; 6():238-43. PubMed ID: 13783140
    [No Abstract]   [Full Text] [Related]  

  • 10. Acne vulgaris treated with triacetyloleandomycin.
    PARKER W
    Med Times; 1962 Mar; 90():310-2. PubMed ID: 14483935
    [No Abstract]   [Full Text] [Related]  

  • 11. Some in vitro susceptibility results with triacetyloleandomycin.
    HORTON GE; DAVIS JW
    Antibiot Chemother (Northfield); 1962 Jun; 12():404-10. PubMed ID: 14449073
    [No Abstract]   [Full Text] [Related]  

  • 12. The challenge of triacetyloleandomycin in pediatric infections.
    NEWSOME CK
    J Indiana State Med Assoc; 1960 Jun; 53():1131-3. PubMed ID: 14426838
    [No Abstract]   [Full Text] [Related]  

  • 13. Generalized eruption from triacetyloleandomycin.
    WELSH AL; EDE M
    Antibiotic Med Clin Ther (New York); 1960 Mar; 7():179-81. PubMed ID: 13843917
    [No Abstract]   [Full Text] [Related]  

  • 14. A study of triacetyloleandomycin in general infections of institutionalized patients.
    CARTER CH
    Antibiotic Med Clin Ther (New York); 1960 Feb; 7():125-8. PubMed ID: 13808017
    [No Abstract]   [Full Text] [Related]  

  • 15. Rapid diagnostic susceptibility tests and prompt therapy with triacetyloleandomycin.
    RIPBERGER FM; ANDERSON RH; PALMER RE
    Antibiotic Med Clin Ther (New York); 1959 Nov; 6():662-9. PubMed ID: 14437535
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic dysfunction associated with triacetyloleandomycin demonstrated by "challenge".
    ROBINSON MM
    Am J Med Sci; 1962 Aug; 244():221-4. PubMed ID: 14492927
    [No Abstract]   [Full Text] [Related]  

  • 17. Triacetyloleandomycin in the treatment of severe infections in infants and children.
    OZYAZICI A; COHEN HJ; PRIGOT A
    Q Rev Pediatr; 1960; 15():102-9. PubMed ID: 14429613
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of otitis media with an oral antibiotic (triacetyloleandomycin).
    FOWLER PD
    Practitioner; 1961 Nov; 187():684-8. PubMed ID: 13894346
    [No Abstract]   [Full Text] [Related]  

  • 19. Triacetyloleandomycin: further observations on the treatment of acne and pyodermas.
    OLANSKY S; MCCORMICK GE
    Antibiot Annu; 1959-1960; 7():652-6. PubMed ID: 14428587
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of dysentery caused by antibiotic-resistant strains with triacetyloleandomycin (Taocin)].
    TOTANI T; YAMANAKA T; IIDA M; INAMURA Y
    Nihon Densenbyo Gakkai Zasshi; 1962 Jul; 36():139-51. PubMed ID: 13922102
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.